BHVN:NYSE, Biohaven Ltd.
BHVN stock overview
Biohaven Ltd. (BHVN:NYSE) closed at $13.65 on November 19, 2026,
up 5.81% on the day.
The stock trades 25.2% below its 52-week high of $18.24
and 70.0% above its 52-week low of $8.03.
Over the past year, it gained 41.7%.
Biohaven Ltd. is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $13.65
- Day change
- +5.81%
- Volume
- 3,261,960
- Average volume
- 3,245,300
- Market cap
- 2B+
- 52-week range
- $8.03 – $18.24
- 50-day average
- $13.41
- 200-day average
- $12.35
Price action over the past year
In 252 trading sessions since November 19, 2025, BHVN closed higher on 113 days (45%).
Its best day was October 22, 2026 (+25.02%) and its worst was September 10, 2026 (-14.73%).
The stock moved 10% or more in a single session 14 times.
It opened at least 5% above the previous day's high 4 times.
Recent signals
BHVN news
-
Nov 19, 2026:
Biohaven Reports Early Tumour Responses in Phase 1 Trial of Cancer Drug BHV-1530
-
Nov 19, 2026:
Biohaven's Novel FGFR3-Directed ADC with Proprietary TopoIx Payload, BHV-1530, Shows Clinical Activity and Confirmed Responses in FGFR3-Altered Urothelial and Head and Neck Cancers, Oral Presentation at ENA 2026
-
Nov 14, 2026:
Could Graves Data Alter The Investment Case For Biohaven (BHVN)?
-
Nov 5, 2026:
Biohaven Drives New Research in Graves' Disease: Phase 3 Pivotal Trial with BHV-1300 Underway and Three Scientific Posters at the 2026 American Thyroid Association Annual (ATA) Meeting
-
Nov 3, 2026:
Pfizer Inc. Q3 2026 Earnings Call Summary
-
Oct 30, 2026:
Is Biohaven (BHVN) Undervalued After Its Narrower Loss And BHV 1420 Data?
-
Oct 29, 2026:
Biohaven Reports Recent Business Developments and Third Quarter 2026 Financial Results
-
Oct 29, 2026:
Wall Street Analysts Believe Biohaven Ltd. (BHVN) Could Rally 43.49%: Here's is How to Trade
About Biohaven Ltd.
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Similar stocks
Find more stocks like BHVN with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.